GREENLIGHT CAPITAL RE, LTD.
For the period ended Mar 31, 2026. Filed May 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Income from Investment in Solasglas
For Q1 2026, Solasglas reported a net gain of 6.8%, compared to a net gain of 7.2% for Q1 2025. The following table provides a breakdown of the gross and net investment return for Solasglas.
| Three months ended March 31 | ||
|---|---|---|
| 2026 | 2025 | |
| Long portfolio gains (losses) | 1.0% | (1.4)% |
| Short portfolio gains (losses) | 5.7% | 5.0% |
| Macro gains (losses) | 1.2% | 4.6% |
| Other income and expenses(1) | (0.3)% | (0.4)% |
| Gross investment return | 7.6% | 7.8% |
| Net investment return(1) | 6.8% | 7.2% |
1 “Other income and expenses” excludes performance compensation but includes management fees. “Net investment return” incorporates both of these amounts. For further information about management fees and performance compensation, refer to Note 3.
For Q1 2026, the significant contributors to Solasglas’ investment income were long positions in gold, Acadia Healthcare (ACHC) and DHT Holdings (DHT). The largest detractors were long positions in U.S. interest rate derivatives, Kyndryl Holdings (KD), and Graphic Packing Holdings (GPK).
Each month, we post the Solasglas investment returns on our website (www.greenlightre.com).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.